AKT1 and neoplasm: Regarding MEG3, a recognized tumor suppressor, it inhibits tumor progression in breast cancer mainly by suppressing AKT signaling and also inhibits capillary angiogenesis in endothelial cells by reducing the expression of tumor angiogenic factors (Lu et al., 2020).